Health and Healthcare

Merck : MRK

All Merck Articles

1067 Articles

Chris Lange | Apr 11, 2018 at 8:30 AM EDT

The Major Pharma Stocks That Are Making Short Sellers Sick

The March 29 short interest data have been compared with the previous figures, and short interest in most of these…

Paul Ausick | Apr 9, 2018 at 4:01 PM EDT

Merck Intel Keep Dow in the Green Monday

Merck, Intel, JPMorgan Chase, and IBM led the Dow to a gain on Monday.

Chris Lange | Apr 9, 2018 at 10:05 AM EDT

Merck Moves Ahead With Late-Stage Trial Win

Shares of Merck had a boost early Monday after the firm announced that its Phase 3 trial of Keytruda for…

Chris Lange | Apr 6, 2018 at 10:05 AM EDT

What Has Tanked Incyte and NewLink Genetics

Incyte saw its shares make a sharp left turn on Friday after the firm gave an update on its late-stage…

Chris Lange | Mar 31, 2018 at 8:40 AM EDT

Major Biopharma Catalysts, Conferences and Decisions to Watch For in April

Here is a 24/7 Wall St. calendar with a few of the biggest biotech and pharmaceutical companies expecting clinical trial…

Paul Ausick | Mar 28, 2018 at 4:01 PM EDT

Merck, Walmart Buoy the Dow Wednesday

Merck and Walmart were among Wednesday's biggest gainers on the Dow while Intel and Cisco were among the big losers.

Chris Lange | Mar 27, 2018 at 8:45 AM EDT

Which Major Pharma Stocks Short Sellers Are Keen On

The March 15 short interest data have been compared with the previous figures, and short interest moves in these selected…

Lee Jackson | Mar 26, 2018 at 8:25 AM EDT

10 Stocks to Buy Now in Case 2019 Bear Market Does Come

The Stifel view is that it is time for investors to take a more defensive posture, but that doesn’t mean…

Chris Lange | Mar 12, 2018 at 8:35 AM EDT

Major Pharma Sees Big Drop in Short Interest

The February 28 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Feb 28, 2018 at 9:10 AM EST

Short Sellers Hike Bets in Major Pharma

The February 15 short interest data have been compared with the previous figures, and short interest in these selected pharmaceutical…

Paul Ausick | Feb 27, 2018 at 4:01 PM EST

Disney, Merck Lead Slide in the Dow Tuesday

The Dow dropped in Tuesday trading, led by downturns at Disney, Merck, Nike, and DowDuPont.

Paul Ausick | Feb 20, 2018 at 4:01 PM EST

Walmart, Verizon Scuttle the DJIA Tuesday

Walmart, General Electric, Merck, and Verizon were biggest losers on the DJIA Tuesday.

Chris Lange | Feb 12, 2018 at 9:35 AM EST

Short Sellers Can’t Make Up Their Minds on Major Pharma

The January 31 short interest data have been compared with the previous figures, and short interest moves in these selected…

Lee Jackson | Feb 8, 2018 at 8:15 AM EST

JPMorgan Likes Big Cap Pharmaceutical Stocks as Market Volatility Jumps

Four large-cap pharmaceutical leaders are rated Overweight at JPMorgan, and all make sense for growth accounts looking for some safety…

Chris Lange | Feb 2, 2018 at 8:59 AM EST

Merck Sees Big Boost From Keytruda in Q4

Merck reported mixed fourth-quarter financial results before the markets opened on Friday.

1 … 22 23 24 25 26 … 72

Merck : MRK

All Merck Articles

The Major Pharma Stocks That Are Making Short Sellers Sick

Merck Intel Keep Dow in the Green Monday

Merck Moves Ahead With Late-Stage Trial Win

What Has Tanked Incyte and NewLink Genetics

Major Biopharma Catalysts, Conferences and Decisions to Watch For in April

Merck, Walmart Buoy the Dow Wednesday

Which Major Pharma Stocks Short Sellers Are Keen On

10 Stocks to Buy Now in Case 2019 Bear Market Does Come

Major Pharma Sees Big Drop in Short Interest

Short Sellers Hike Bets in Major Pharma

Disney, Merck Lead Slide in the Dow Tuesday

Walmart, Verizon Scuttle the DJIA Tuesday

Short Sellers Can’t Make Up Their Minds on Major Pharma

JPMorgan Likes Big Cap Pharmaceutical Stocks as Market Volatility Jumps

Merck Sees Big Boost From Keytruda in Q4

A Couple With $3.5 Million Discovers State Estate Taxes Could Cost Their Kids Six Figures

MISL Investors: Watch the FY27 Budget Bill Before the Next Rally

SMH Has Crushed the S&P 500 by 2,041% Over a Decade, But Recent 42% Rally Signals Dangerous Valuations

A Couple With $3.5 Million Discovers State Estate Taxes Could Cost Their Kids Six Figures

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month

A Couple With $3.5 Million Discovers State Estate Taxes Could Cost Their Kids Six Figures

MISL Investors: Watch the FY27 Budget Bill Before the Next Rally

Merck : MRK

All Merck Articles

The Major Pharma Stocks That Are Making Short Sellers Sick

Merck Intel Keep Dow in the Green Monday

Merck Moves Ahead With Late-Stage Trial Win

What Has Tanked Incyte and NewLink Genetics

Major Biopharma Catalysts, Conferences and Decisions to Watch For in April

Merck, Walmart Buoy the Dow Wednesday

Which Major Pharma Stocks Short Sellers Are Keen On

10 Stocks to Buy Now in Case 2019 Bear Market Does Come

Major Pharma Sees Big Drop in Short Interest

Short Sellers Hike Bets in Major Pharma

Disney, Merck Lead Slide in the Dow Tuesday

Walmart, Verizon Scuttle the DJIA Tuesday

Short Sellers Can’t Make Up Their Minds on Major Pharma

JPMorgan Likes Big Cap Pharmaceutical Stocks as Market Volatility Jumps

Merck Sees Big Boost From Keytruda in Q4

A Couple With $3.5 Million Discovers State Estate Taxes Could Cost Their Kids Six Figures

MISL Investors: Watch the FY27 Budget Bill Before the Next Rally

SMH Has Crushed the S&P 500 by 2,041% Over a Decade, But Recent 42% Rally Signals Dangerous Valuations

Featured Reads

A Couple With $3.5 Million Discovers State Estate Taxes Could Cost Their Kids Six Figures

A 71-Year-Old's $850,000 Home Is Her Biggest Retirement Asset. Downsizing Could Add $2,250 a Month